Trial record 1 of 63 for:    phase I study of mozobil
Previous Study | Return to List | Next Study

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
ClinicalTrials.gov Identifier:
NCT00967785
First received: August 27, 2009
Last updated: May 11, 2016
Last verified: March 2016